Activity of daptomycin against Listeria monocytogenes isolates from cerebrospinal fluid

Antimicrobial Agents and Chemotherapy

Volumn 52, Issue 5, 2008, Pages 1850-1851

  Spanjaard, Lodewijk ^a   Vandenbroucke Grauls, Christina M J E ^a,b  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AGAR; DAPTOMYCIN;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL MENINGITIS; BACTERIUM ISOLATE; BROTH DILUTION; CEREBROSPINAL FLUID; CONTROLLED STUDY; DRUG EFFICACY; DRUG INDICATION; EPSILOMETER TEST; LISTERIA MONOCYTOGENES; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; DAPTOMYCIN; HUMANS; LISTERIA INFECTIONS; LISTERIA MONOCYTOGENES; MICROBIAL SENSITIVITY TESTS; NETHERLANDS;

EID: 42949127072     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.01139-07     Document Type: Article

References (18)

1. Clinical and Laboratory Standards Institute. 2006. Methods for antimicrobial dilution and disk susceptibility testing of infrequently isolated or fastidious bacteria. Approved standard M45-A. Clinical and Laboratory Standards Institute, Wayne, PA.
2. Cottagnoud, P., M. Pfister, F. Acosta, M. Cottagnoud, L. Flatz, F. Kühn, H. P. Müller, and A. Stucki. 2004. Daptomycin is highly efficacious against penicillin-resistant and penicillin- and quinolone-resistant pneumococci in experimental meningitis. Antimicrob. Agents Chemother. 48:3928-3933.
3. Doorduyn, Y., C. M. de Jager, W. K. van der Zwaluw, W. J. B. Wannet, A. van der Ende, L. Spanjaard, and Y. T. H. P. van Duynhoven. 2006. Invasive Listeria monocytogenes infections in the Netherlands, 1995-2003. Eur. J. Clin. Microbiol. Infect. Dis. 25:433-442.
4. Dvorchik, B. H., D. Brazier, M. F. DeBruin, and R. D. Arbeit. 2003. Daptomycin pharmacokinetics and safety following administration of escalating doses once daily to healthy subjects. Antimicrob. Agents Chemother. 47: 1318-1323.
5. Gerber, P., A. Stucki, F. Acosta, M. Cottagnoud, and P. Cottagnoud. 2006. Daptomycin is more efficacious than vancomycin against a methicillin-susceptible Staphylococcus aureus in experimental meningitis. J. Antimicrob. Chemother. 57:720-723.
6. Hancock, R. E. 2005. Mechanisms of action of newer antibiotics for gram-positive pathogens. Lancet Infect. Dis. 5:209-218.
7. Haworth, C. S., M. W. Sobieski, W. M. Scheld, and T. S. Park. 1990. Staphylococcus aureus ventriculitis treated with single-dose intraventricular vancomycin or daptomycin (LY146032): bacterial and antibiotic kinetics in hydrocephalic rabbits. Antimicrob. Agents Chemother. 34:245-251.
8. Hindler, J. F., and J. B. Patel. 2007. Susceptibility test methods: fastidious bacteria, p. 1193-1213. In P. R. Murray, E. J. Baron, J. H. Jorgensen, M. L. Landry, and M. A. Pfaller (ed.), Manual of clinical microbiology, 9th ed., vol. 1. ASM Press, Washington, DC.
9. Huang, Y. T., C. H. Liao, L. J. Teng, and P. R. Hsueh. 2007. Daptomycin susceptibility of unusual gram-positive bacteria: comparison of results obtained by the Etest and the broth microdilution method. Antimicrob. Agents Chemother. 51:1570-1572.
10. Jorgensen, J. H., and S. A. Crawford. 2006. Assessment of two commercial susceptibility test methods for determination of daptomycin MICs. J. Clin. Microbiol. 44:2126-2129.
11. King, A., and I. Phillips. 2001. The in vitro activity of daptomycin against 514 gram-positive aerobic clinical isolates. J. Antimicrob. Chemother. 48:219-223.
12. Netherlands Reference Laboratory for Bacterial Meningitis. 2006. Bacterial meningitis in the Netherlands. Annual report 2005. University of Amsterdam, The Netherlands.
13. Piper, K. E., J. M. Steckelberg, and R. Patel. 2005. In vitro activity of daptomycin against clinical isolates of gram-positive bacteria. J. Infect. Chemother. 11:207-209.
14. Safdar, N., D. Andes, and W. A. Craig. 2004. In vivo pharmacodynamic activity of daptomycin. Antimicrob. Agents Chemother. 48:63-68.
15. Spanjaard, L., P. Bol, W. Ekker, and H. C. Zanen. 1985. The incidence of bacterial meningitis in the Netherlands; a comparison of three registration systems, 1977-1982. J. Infect. 11:259-268.
16. Steenbergen, J. N., J. Alder, G. M. Thorne, and F. P. Tally. 2005. Daptomycin: a lipopeptide antibiotic for the treatment of serious gram-positive infections. J. Antimicrob. Chemother. 55:283-288.
17. Streit, J. M., R. N. Jones, and H. S. Sader. 2004. Daptomycin activity and spectrum: a worldwide sample of 6737 clinical gram-positive organisms. J. Antimicrob. Chemother. 53:669-674.
18. Tunkel, A. R., and W. M. Scheld. 2005. Acute meningitis, p. 1083-1126. In G. L. Mandell, J. E. Bennett, and R. Dolin (ed.), Mandell, Douglas, and Bennett's principles and practice of infectious diseases. 6th ed., vol. 1. Elsevier, Philadelphia, PA.